Relay Therapeutics

CIK 0001812364 · Biotech · Public

Motion-based drug discovery platform that designs protein inhibitors by modeling dynamic protein conformations

relaytx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$30M
1 Form D · Jan 2024
33 months since last filing
Contracts
—
No federal contracts on record
Patents
40
3 granted · 37 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$30,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2300Retrotope, Inc.—$32M
2301Basking Biosciences—$29M
2302GALATEA BIO INC—$3.7M
2303Relay Therapeutics—$30M
2304Acurx Pharmaceuticals, Inc.—$17M
2305Congruence Therapeutics——
2306BICYCLE THERAPEUTICS PLC—$555M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 12 related persons
  • Brian AdamsExecutive Officer
  • Donald BergstromExecutive Officer
  • Alexis BorisyDirector
  • Thomas CatinazzoExecutive Officer
  • Linda HillDirector
  • Douglas IngramDirector
  • Sekar KathiresanDirector
  • Mark MurckoDirector
  • Sanjiv PatelDirector · Executive Officer
  • Peter RahmerExecutive Officer
  • Jami RubinDirector
  • Laura ShawverDirector

Patents

USPTO · 3 granted of 40
  • Cdk Inhibitors And Methods Of Use Thereofapplication
  • Bifunctional PI3K-ALPHA Inhibitors And Uses Thereofapplication
  • PI3K-ALPHA Inhibitors And Methods Of Making And Using The Sameapplication
  • Solid Forms Of A Cdk Inhibitorapplication
  • PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
  • Estrogen Receptor Alpha Degraders And Methods Of Use Thereofapplication
  • PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
  • Fgfr Inhibitors And Methods Of Making And Using The Sameapplication
  • PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
  • PI3K-ALPHA Inhibitors And Methods Of Use Thereofapplication
  • Fgfr Inhibitors And Methods Of Making And Using The Samegranted
  • JAK2 Inhibitors And Methods Of Use Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.